Poster apresentado no EPA2024: 32nd European Congress of Psychiatry.
Background: Considering that in Portugal, in 2020, 60.000 people were diagnosed with cancer and 50% died of the disease, it is not surprising that the diagnosis and subsequent stages, including survival, are marked by recurrent concerns and fears that the disease progresses negatively or reoccurs, with all its biopsychosocial consequences. Although this Fear of Progression/Recurrence is realistic and is part of...